未登录Building the US-ASEAN Consortium for Pharmacy Education based on the US-Thai Consortium experience: a qualitative study基于美泰药学教育联盟的经验建立美东盟药学教育联盟：一项定性研究
Sookaneknun Olson, Phayom; Nathisuwan, Surakit; Katz, Michael D.; Srimongkon, Pornchanok; Jungnickel, Paul W.; Ploylearmsang, Chanuttha; Leelathanalerk, Areerut; Ryan, Melody; Doungngern, Thitima; Oderda, Gary M.; Lau, Alan H.; Pattharachayakul, Sutthiporn; Wattanachai, Pansakon; Nimworapan, Mantiwee; Seesin, Theerapong; Potisarach, Pemmarin .png)
分享.png)
收藏BUDGET IMPACT OF RIBOCICLIB PLUS LETROZOLE FOR THE TREATMENT OF POST-MENOPAUSAL WOMEN WITH HORMONE RECEPTOR-POSITIVE (HR plus ), HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR 2-NEGATIVE (HER2-) ADVANCED OR METASTATIC BREAST CANCER FROM A US PRIVATE THIRD-PARTY PAYER PERSPECTIVEMistry, R.; Suri, G.; Young, K. C.; Hettle, R.; May, J. R.; Brixner, D.; Oderda, G.; Biskupiak, J.; Tang, D.; Bhattacharyya, D.; Bhattacharyya, S.; Mishra, D.; Dalal, A. 分享 收藏 COST EFFECTIVENESS OF RIBOCICLIB PLUS LETROZOLE VERSUS PALBOCICLIB PLUS LETROZOLE FOR THE TREATMENT OF POST-MENOPAUSAL WOMEN WITH HORMONE RECEPTOR-POSITIVE (HR plus ), HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR 2-NEGATIVE (HER2-) ADVANCED OR METASTATIC BREAST CANCER FROM A US PRIVATE THIRD-PARTY PAYER PERSPECTIVESuri, G.; Mistry, R.; Young, K. C.; Hettle, R.; May, J. R.; Brixner, D.; Oderda, G.; Biskupiak, J.; Tang, D.; Bhattacharyya, D.; Bhattacharyya, S.; Mishra, D.; Dalal, A. 分享 收藏 分享 收藏 PROJECTING THE COST, UTILIZATION, AND PATIENT CARE IMPACT OF PRESCRIBING EXTENDED RELEASE NON-ABUSE-DETERRENT OPIOIDS TO CHRONIC PAIN PATIENTSWhite, A. G.; Yenikomshian, M.; Carson, M. E.; Garrison, L. P.; Oderda, G.; Biskupiak, J. E.; Hlavacek, P.; Roland, C. L. 分享 收藏 分享 收藏 分享 收藏 分享 收藏 分享 收藏 分享 收藏 分享 收藏 分享 收藏 分享 收藏 分享 收藏 分享 收藏 分享 收藏 分享 收藏 分享 收藏 分享 收藏 分享 收藏 
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
